Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.324
Peer-review started: March 19, 2023
First decision: April 28, 2023
Revised: May 11, 2023
Accepted: May 22, 2023
Article in press: May 22, 2023
Published online: June 26, 2023
Processing time: 98 Days and 16.3 Hours
Anti-hypertensive education is an important public health intervention to decrease the mortality and burden of the disease. Using digital technologies for education as a part of preventive measures for hypertension is a cost-effective approach and helps low-income communities and vulnerable populations overcome barriers to healthcare access. The coronavirus disease 19 pandemic further highlighted the need of new health interventions to address health inequalities. Virtual education is helpful to improve awareness, knowledge, and attitude toward hypertension. However, given the complexity of behavioral change, educational approaches do not always provide a change in behavior. Some of the obstacles in online hypertensive education could be time limitations, not being tailored to individual needs and not including the different elements of behavioral models to enhance behavior change. Studies regarding virtual education should be encouraged and involve lifestyle modifications emphasizing the importance of Dietary Approaches to Stop Hypertension diet, salt restriction, and exercise and should be used adjunct to in-person visits for the management of hypertension. Additionally, to stratify patients according to hypertension type (essential or secondary) would be useful to create specific educational materials. Virtual hypertension education is promising to increase awareness regarding risk factors and most importantly motivate patients to be more compliant with management helping to decrease hypertension related complications and hospitalizations.
Core Tip: Online anti-hypertensive education can play an important role in preventing and managing hypertension by providing individuals with the knowledge and resources they need to make lifestyle changes. Hypertensive management and education can be difficult in certain populations due to lack of access to healthcare, lack of information, and social determinants of health. Virtual education would promote health in those vulnerable populations.
- Citation: Yukselen Z, Singh Y, Malempati S, Dasari M, Arun Kumar P, Ramsaran E. Virtual patient education for hypertension: The truth about behavioral change. World J Cardiol 2023; 15(6): 324-327
- URL: https://www.wjgnet.com/1949-8462/full/v15/i6/324.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i6.324
In a recent article titled “Impact of the virtual anti-hypertensive educational campaign towards knowledge, attitude, and practice of hypertension management during the COVID-19 pandemic”, Andrianto et al[1] emphasized the importance of online education in patients with hypertension[1]. Given the burden of hypertension, we found this article very interesting and promising for health promotion. Hypertension has been described as the "largest epidemic ever known to mankind"[2]. In the United States, nearly half of the adults have hypertension, and only 25% are under control[3]. Being an epidemic globally, it’s not surprising that the economic burden of hypertension is enormous. In the United States itself, hypertension costs about $131 billion each year[4]. From the public health intervention perspective, Andrianto et al's study is brilliant as we believe that one of the ways to cut the cost of hypertension is community-based interventions, such as health education and support groups, which can help reduce the cost of hypertension by providing individuals with the information and resources they need to manage their condition effectively[1].
As highlighted by the authors, overall, the coronavirus disease 19 (COVID-19) pandemic has had a significant impact on health disparities and healthcare access[5]. Even in the non-COVID era, patients with low economic status have been disproportionately affected by hypertension. The Prospective Urban Rural Epidemiology study, including patients from 17 countries on five continents, showed that awareness, diagnosis, and control of hypertension were lower in low-income countries compared with other countries and in rural settings compared with urban areas[6]. Considering the disadvantages of the vulnerable population, the COVID-19 pandemic highlighted the importance of addressing health disparities to ensure that all individuals have access to the care they need. Some of the difficulties in the population-level management of hypertension for minorities are barriers to healthcare, awareness, and understanding of the importance of monitoring, which is often linked to social determinants of health such as poverty, cultural beliefs, illiteracy, discrimination, and language barriers[7].
In the current era, the increasing use of mobile applications and telemedicine for communication has the potential to bridge disparities and play a significant role in managing hypertension in outpatient settings. A study by Freund et al[8] suggests that even elderly patients can effectively use online interventions as an inexpensive way to find answers to their health-related questions and improve their medical knowledge[8]. To address the global burden of hypertension, the Lancet commission encourages governments, pharmaceutical companies, healthcare professionals, and professional societies to develop simple mobile apps and online education programs to provide equal basic health access to people in low-income and middle-income countries[9]. In sync with this concept, the study conducted by Andrianto et al[1] reveals the importance of anti-hypertensive education in lower-middle-income countries. They found that virtual anti-hypertensive educational campaign implementation led to a significant improvement in the knowledge and attitude of patients with hypertension; however, it did not reflect a change in patient practice in taking measures against hypertension[1].
We are curious as to why a prospective study such as this with robust methodology could detect an improvement in facets of hypertension management but could not alter patient behavior. The education provided by Andrianto et al[1] was mainly directed toward the Dietary Approaches to Stop Hyper
The other reason could be a limited time of education and a lack of other intervention components. According to the behavior change wheel model, ten different intervention functions have been suggested, some of them being education, incentivization, persuasion, training, and enablement[15]. Given the complexity of behavior change required in hypertension; applying those intervention elements, such as providing patient-centered, tailored information and feedback by the healthcare professionals, would be required. Virtual education can also be tailored to an individual's specific needs and preferences. For example, some virtual programs may offer personalized meal and exercise plans, while others may provide resources and support for stress management or medication management. Although the study by Andrianto et al[1] did not show a major behavior change, it greatly impacted the patient’s perception towards not stopping medications when the BP is under control. This is another achievement of this study, as patients obtained that awareness after education.
Lastly, we noticed that the inclusion criteria were all patients with a diagnosis of hypertension. Did the authors sub-stratify their findings for the etiology of hypertension (essential vs secondary)? It would be valuable to learn how many patients amongst the included 110 participants had secondary/renovascular etiology of hypertension, especially since Table 2 indicates that 30 participants were < 40 years, which is when secondary hypertension is more prevalent. Both pharmacologic and non-pharmacologic measures differ for secondary hypertension and could be a reason for not reflecting in the behavioral change of patients.
To conclude, this randomized clinical trial has nicely addressed the importance of virtual hype
Provenance and peer review: Unsolicited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Cardiac and cardiovascular systems
Country/Territory of origin: United States
Peer-review report’s scientific quality classification
Grade A (Excellent): 0
Grade B (Very good): B, B
Grade C (Good): 0
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Freund O, Israel; Tostes RC, Brazil S-Editor: Fan JR L-Editor: A P-Editor: Fan JR
1. | Andrianto A, Ardiana M, Nugraha RA, Yutha A, Khrisna BPD, Putra TS, Shahab AR, Andrianto H, Kikuko IH, Puspitasari AN, Hajjrin MR. Impact of the virtual anti-hypertensive educational campaign towards knowledge, attitude, and practice of hypertension management during the COVID-19 pandemic. World J Cardiol. 2022;14:626-639. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis (1)] |
2. | Yusuf S, Wood D, Ralston J, Reddy KS. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet. 2015;386:399-402. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 11.2] [Reference Citation Analysis (0)] |
3. | Cascade CH. Hypertension Prevalence, Treatment and Control Estimates among US Adults Aged 18 Years and Older Applying the Criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline-NHANES 2015–2018. Atlanta, Georgia: US Department of Health and Human Services (HHS); 2021. [Cited in This Article: ] |
4. | Kirkland EB, Heincelman M, Bishu KG, Schumann SO, Schreiner A, Axon RN, Mauldin PD, Moran WP. Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003-2014. J Am Heart Assoc. 2018;7. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 107] [Cited by in F6Publishing: 166] [Article Influence: 27.7] [Reference Citation Analysis (0)] |
5. | Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health. 2020;74:964-968. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 395] [Cited by in F6Publishing: 654] [Article Influence: 163.5] [Reference Citation Analysis (0)] |
6. | Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959-968. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1154] [Cited by in F6Publishing: 1230] [Article Influence: 111.8] [Reference Citation Analysis (0)] |
7. | Blas E, Kurup AS. Equity, social determinants and public health programmes. Switzerland: World Health Organization; 2010. [Cited in This Article: ] |
8. | Freund O, Reychav I, McHaney R, Goland E, Azuri J. The ability of older adults to use customized online medical databases to improve their health-related knowledge. Int J Med Inform. 2017;102:1-11. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis (0)] |
9. | O'Brien E. The Lancet Commission on hypertension: Addressing the global burden of raised blood pressure on current and future generations. J Clin Hypertens (Greenwich). 2017;19:564-568. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis (0)] |
10. | Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3558] [Cited by in F6Publishing: 3318] [Article Influence: 144.3] [Reference Citation Analysis (0)] |
11. | Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-1124. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3896] [Cited by in F6Publishing: 3608] [Article Influence: 133.6] [Reference Citation Analysis (0)] |
12. | He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 806] [Cited by in F6Publishing: 860] [Article Influence: 78.2] [Reference Citation Analysis (0)] |
13. | Swift DL, McGee JE, Earnest CP, Carlisle E, Nygard M, Johannsen NM. The Effects of Exercise and Physical Activity on Weight Loss and Maintenance. Prog Cardiovasc Dis. 2018;61:206-213. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 168] [Cited by in F6Publishing: 252] [Article Influence: 42.0] [Reference Citation Analysis (0)] |
14. | Ozemek C, Phillips SA, Popovic D, Laddu-Patel D, Fancher IS, Arena R, Lavie CJ. Nonpharmacologic management of hypertension: a multidisciplinary approach. Curr Opin Cardiol. 2017;32:381-388. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis (0)] |
15. | Michie S, Atkins L, West R. The behaviour change wheel. A guide to designing interventions. 1st ed. Great Britain: Silverback Publishing; 2014: 1003-1010. [Cited in This Article: ] |